ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.02%
Brent Oil
72.72
0.00%
Bitcoin
97,686.26
-0.07%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Arcutis Biotherapeutics Inc (ARQT) Cotización

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc (ARQT)

NASDAQ
14.99
0.88
(6.24%)
Cerrado 21 Diciembre 3:00PM
Delayed by 15 minutes
15.11
0.12
(0.80%)
Fuera de horario: 6:12PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
15.11
Postura de Compra
13.25
Postura de Venta
17.30
Volume Operado de la Acción
5,216,399
14.11 Rango del Día 15.79
2.45 Rango de 52 semanas 15.20
Capitalización de Mercado [m]
1.769B
Precio Anterior
14.11
Precio de Apertura
14.11
Hora
4
@
15.2
Última hora de negociación
Volumen financiero
US$ 79,417,067
Precio Promedio Ponderado
15.2245
Volumen promedio (3 m)
2,011,042
Acciones en circulación
117,044,591
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-6.70
Beneficio por acción (BPA)
-2.24
turnover
59.61M
Beneficio neto
-262.14M

Acerca de Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.arcutis.com
Sede
Wilmington, Delaware, USA
Fundado
-
Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARQT. The last closing price for Arcutis Biotherapeutics was US$14.11. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of US$ 2.45 to US$ 15.20.

Arcutis Biotherapeutics currently has 117,044,591 shares in issue. The market capitalisation of Arcutis Biotherapeutics is US$1.65 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -6.70.

Flujo de Opciones Arcutis Biotherapeutics (ARQT)

Ver flujo de opciones completo

Flujo General

Optimista

Prima Neta

695k

Calls / Puts

350.00%

Comp. / Vent.

80.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

ARQT Últimas noticias

Más noticias

Form 144 - Report of proposed sale of securities

15 horas hace
Edgar (US Regulatory)

Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability...

16 Diciembre 2024
GlobeNewswire Inc.

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful...

06 Diciembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

03 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Diciembre 2024
Edgar (US Regulatory)

Arcutis Announces Promotions on Executive Management Team

Strategic appointments support further growth and position Company for future success WESTLAKE VILLAGE, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

03 Diciembre 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

02 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
12.8623.346938775512.2515.212.12270960213.84643133CS
44.8847.702834799610.2315.210.05204601612.6772778CS
125.8663.35135135149.2515.28.03201104210.60645665CS
267.0186.54320987658.115.27.86219821810.10538594CS
5212.58497.2332015812.5315.22.4532111548.44097956CS
156-1.69-10.059523809516.827.41.7618154118.9135517CS
260-7.94-34.446854663823.0540.881.76118223310.01373088CS

ARQT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Arcutis Biotherapeutics?
El precio actual de las acciones de Arcutis Biotherapeutics es US$ 15.11
¿Cuántas acciones de Arcutis Biotherapeutics están en circulación?
Arcutis Biotherapeutics tiene 117,044,591 acciones en circulación
¿Cuál es la capitalización de mercado de Arcutis Biotherapeutics?
La capitalización de mercado de Arcutis Biotherapeutics es USD 1.65B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Arcutis Biotherapeutics?
Arcutis Biotherapeutics ha negociado en un rango de US$ 2.45 a US$ 15.20 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Arcutis Biotherapeutics?
El ratio precio/beneficio de Arcutis Biotherapeutics es -6.7
¿Cuál es el ratio de efectivo a ventas de Arcutis Biotherapeutics?
El ratio de efectivo a ventas de Arcutis Biotherapeutics es 29.47
¿Cuál es la moneda de reporte de Arcutis Biotherapeutics?
Arcutis Biotherapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Arcutis Biotherapeutics?
El último ingresos anual de Arcutis Biotherapeutics es USD 59.61M
¿Cuál es el último beneficio anual de Arcutis Biotherapeutics?
El último beneficio anual de Arcutis Biotherapeutics es USD -262.14M
¿Cuál es la dirección registrada de Arcutis Biotherapeutics?
La dirección registrada de Arcutis Biotherapeutics es 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
¿Cuál es la dirección del sitio web de Arcutis Biotherapeutics?
La dirección del sitio web de Arcutis Biotherapeutics es www.arcutis.com
¿En qué sector industrial opera Arcutis Biotherapeutics?
Arcutis Biotherapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

ARQT Discussion

Ver más
Monksdream Monksdream 3 meses hace
ARQT under $15
👍️0
52172 52172 4 meses hace
Ath’s incoming
👍️0
52172 52172 4 meses hace
Put the crackpipe down
👍️0
52172 52172 4 meses hace
Wrong we beat big time sucka
👍️0
52172 52172 4 meses hace
12 coming
👍️0
Sierra20 Sierra20 4 meses hace
$6 coming
👍️0
Sierra20 Sierra20 4 meses hace
Earnings missed big time and this tanks hard
👍️0
52172 52172 5 meses hace
Not yet need 20’s which will come
👍️ 1
MiamiGent MiamiGent 5 meses hace
ARQT $10.82 HOD!
Everybody happy?
👍️0
52172 52172 5 meses hace
Some large transactions happening a sign of whats to come
👍️ 1
52172 52172 5 meses hace
Gonna close green watch
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT The short interest is about 25%
The free trading float is tiny.
Share Price should rise steadily today.
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
Steadily rising, as I expected.

The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.
👍️0
52172 52172 5 meses hace
Im hoping!
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

6:28 AM this morning
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

I am going to buy this product- I have psoriasis all over, except my face thank God.
👍️0
52172 52172 5 meses hace
Real revenue is gonna begin to come in.
👍️0
52172 52172 5 meses hace
Headed to 20’s soon enough!
👍️0
MiamiGent MiamiGent 5 meses hace
$ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
The boys will run this tomorrow.
👍️0
MiamiGent MiamiGent 5 meses hace
$ARQT
Arcutis Biotherapeutics Inc

My guess it'll be $11 by 8PM.
The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
Bullish
👍️0
MiamiGent MiamiGent 5 meses hace
$ARQT Tight Bid and ASK now.
Getting serious.
Bid ARCX
10.55 x 10
Ask XNMS
10.59 x 1
Volume
2,437,578
Bullish
👍️0
MiamiGent MiamiGent 5 meses hace
$ARQT
Arcutis Biotherapeutics Inc

I told ya!
Currently in AH
Bid XNMS 10.50 x 13
Ask ARCX 10.67 x 20
Volume
2,429,849
Bullish
👍️0
MiamiGent MiamiGent 5 meses hace
$ARQT New traders: Look at those big $10.48 buys!
The few that follow are "paint jobs"- shorts trying to paint weakness.
Pay attention to the big buys!
$ARQT
18:07:49 $10.41 5 paint job
18:07:49 $10.35 20 paint job
18:07:45 $10.48 15 paint job
18:07:25 $10.48 7,900 real buy
18:07:25 $10.48 1,500 real buy
18:07:01 $10.3567 30
18:05:44 $10.49 115
18:04:57 $10.49 9,400
18:04:26 $10.4887 110
18:03:38 $10.42 6,212
18:03:38 $10.42 2,200
Bullish
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!
👍️0
Sierra20 Sierra20 5 meses hace
I hope it will be approved. I think it will be approved. It’s just weird.
👍️0
MiamiGent MiamiGent 5 meses hace
You're being unnecessarily doomsdayish, Sierra.

Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
MG
👍️0
Sierra20 Sierra20 5 meses hace
CRL more than likely. I knew it. F! This is horrible!!!!
https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/
👍️0
Sierra20 Sierra20 5 meses hace
They got CRL. 😔
There’s no other reason for this delay. Back to $5 I think.
👍️0
Sierra20 Sierra20 5 meses hace
I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.
👍️0
MiamiGent MiamiGent 5 meses hace
ARQT Only 40 more minutes for FDA to announce today.
One time it did at 11:30 PM and it was a QUADRUPLE!
👍️0
MiamiGent MiamiGent 5 meses hace
You must be short. There's no basis for what you are saying.
👍️0
MiamiGent MiamiGent 5 meses hace
AQRT I'm in today.
👍️0
Sierra20 Sierra20 5 meses hace
CRL coming at 4 pm est. imo.
👍️0
Sierra20 Sierra20 5 meses hace
I think CRL coming…
👍️0
Sierra20 Sierra20 5 meses hace
Run
👍️0
52172 52172 5 meses hace
Havent missed nothing yet!
👍️0
52172 52172 5 meses hace
Monday boom!
👍️0
Sierra20 Sierra20 6 meses hace
I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.
👍️0
Sierra20 Sierra20 6 meses hace
Oh no!!!!!
👍️0
Sierra20 Sierra20 6 meses hace
CRL? Delayed? What’s going on?
👍️0
Monksdream Monksdream 6 meses hace
ARQT under$10
👍️0
52172 52172 6 meses hace
No one knows shit approval is imminent
👍️0
Sierra20 Sierra20 6 meses hace
Someone knows something sell off started. 😔
👍️0
Sierra20 Sierra20 6 meses hace
I hope they didn’t get a CRL. People are selling. Something is going on.
👍️0
52172 52172 6 meses hace
408k share buy ah’s nothing else needed to say!
👍️0
52172 52172 6 meses hace
20’s imminent mark this post
👍️0
52172 52172 7 meses hace
Load the boat easy money
👍️0
52172 52172 7 meses hace
Buy opp!
👍️0
52172 52172 7 meses hace
ER coming on the 14th might get a bump then data in july
👍️0
Monksdream Monksdream 8 meses hace
ARQT under $10
👍️0

Su Consulta Reciente

NASDAQ
ARQT
Arcutis Biotherapeutics
TG
9SC
Manganese X Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados